HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis of 4-amidomethyl-1-glucosyl-1,2,3-triazoles and evaluation as glycogen phosphorylase inhibitors.

Abstract
Glycogen phosphorylase (GP) appears as a key enzyme for the control of hyperglycemia in the context of type 2 diabetes. In order to gain additional data for structure-activity studies of the inhibition of this enzyme, a series of eight GP inhibitor candidates were prepared from peracetylglucopyranosyl azide 1 by click-chemistry. The need for a N-Boc-protected propargylamine was identified in the CuAAC with azide 1 under Meldal's conditions, while Sharpless' conditions were better adapted to the CuAAC of azide 1 with propargyl bromide. Cycloaddition of Boc-propargylamine with azide 1 afforded the N-Boc precursor of a 4-aminomethyl-1-glucosyl-1,2,3-triazole which gave access to a series of eight amide and sulfonamide derivatives. After deacetylation, enzymatic studies revealed poor to moderate inhibitions toward this enzyme. The N-Boc-protected amine was the best inhibitor (IC50=620 μM) unexpectedly slightly better than the 2-naphthylamido substituted analogue (IC50=650 μM).
AuthorsDavid Goyard, Tibor Docsa, Pál Gergely, Jean-Pierre Praly, Sébastien Vidal
JournalCarbohydrate research (Carbohydr Res) Vol. 402 Pg. 245-51 (Jan 30 2015) ISSN: 1873-426X [Electronic] Netherlands
PMID25498027 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ltd. All rights reserved.
Chemical References
  • Enzyme Inhibitors
  • Triazoles
  • Glycogen Phosphorylase
Topics
  • Animals
  • Chemistry Techniques, Synthetic
  • Enzyme Inhibitors (chemical synthesis, chemistry, pharmacology)
  • Glycogen Phosphorylase (antagonists & inhibitors)
  • Glycosylation
  • Hydrophobic and Hydrophilic Interactions
  • Rabbits
  • Stereoisomerism
  • Structure-Activity Relationship
  • Triazoles (chemical synthesis, chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: